In the US, Ramelteon (ramelteon systemic) is a member of the drug class miscellaneous anxiolytics, sedatives and hypnotics and is used to treat Insomnia.
US matches:
- Ramelteon
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
N05CH02
CAS registry number (Chemical Abstracts Service)
0196597-26-9
Chemical Formula
C16-H21-N-O2
Molecular Weight
259
Therapeutic Categories
Treatment of insomnia
Melatonin receptor agonist
Chemical Names
(-)-(S)-N-[2-(2,6,7,8-Tetrahydro-1H-indeno[5,4-b]furan-8-yl)ethyl]propionamid (IUPAC)
N-{2-[(8S)-1,6,7,8-tetrahydro-2H-indeno[5,4-b]furan-8-yl]ethyl}=propanamide (WHO)
Propanamide, N-(2-((8S)-1,6,7,8-tetrahydro-2H-indeno(5,4-b)furan-8-yl)ethyl)-
Foreign Names
- Ramelteonum (Latin)
- Ramelteon (German)
- Rameltéon (French)
- Ramelteón (Spanish)
Generic Names
- Ramelteon (OS: BAN, USAN)
- TAK-375 (IS: Takeda)
Brand Names
- Rozerem
Takeda, Japan; Takeda, United States
International Drug Name Search
Glossary
BAN | British Approved Name |
IUPAC | International Union of Pure and Applied Chemistry |
IS | Inofficial Synonym |
OS | Official Synonym |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
USAN | United States Adopted Name |
WHO | World Health Organization |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment